DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials

• Morgan C,
• Jin X,
• Yu X,
• De Rosa S,
• Kublin J,
• Metch B,
• Keefer M,
• NIAID H

Affiliations

Morgan C

Jin X

Yu X

De Rosa S

Kublin J

Metch B

Keefer M

NIAID H